Anamnesis Bio
Anamnesis Bio42
About
What does Anamnesis Bio do?
Anamnesis Bio is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. They leverage a deep understanding of disease mechanisms to create targeted therapies with the potential to significantly impact patient outcomes. Their approach aims to address unmet needs in conditions like Alzheimer's and Parkinson's.
Where is Anamnesis Bio headquartered?
Anamnesis Bio is headquartered in תל אביב - יפו, Israel.
When was Anamnesis Bio founded?
Anamnesis Bio was founded in 2023.
What industry does Anamnesis Bio operate in?
Anamnesis Bio operates in Biotech, HealthTech, Drug Discovery, Neurotech, Longevity, Genomics.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
AI-powered platform for personalized health and longevity.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.